Bal Pharma Limited Share Price & Analysis

Indian firm wins FDA approval for superbug antibiotic

*Indian firm wins FDA approval for superbug antibiotic* — Glenmark Pharmaceuticals receives US FDA nod for its novel antibiotic, marking a breakthrough in treating drug-resistant infections. The approved drug targets serious bacterial infections with limited treatment options. This paves the way for US market entry and potential revenue growth. Approval underscores India’s rising role in global pharma innovation. 📊 *STOCKS:* GLENMARK | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #FDA

Sun Pharma makes biggest global acquisition

*Sun Pharma makes biggest global acquisition*. Sun Pharma has announced its largest global acquisition to date, expanding its international footprint. The deal is valued at **$4 billion**, marking a significant move in the global pharma space. This strategic purchase strengthens its specialty portfolio and presence in high-growth markets. 📊 *STOCKS:* SUNPHARMA | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Acquisition

Cdymax receives FDA warning letter on drug testing practices

*Indian API maker Cdymax hit with FDA warning letter tied to drug ingredients testing.* The company received a regulatory notice from the US FDA regarding deficiencies in its drug ingredient testing procedures. This warning letter signals compliance concerns at the manufacturing facility and may impact its ability to supply APIs to global pharma clients. Investors should monitor for remedial action updates and potential client impacts. 📊 *SECTOR:* Pharma | #MEDIUMIMPACT #Regulatory

Novo Nordisk hacked by cyber extortion group FulcrumSec

*Novo Nordisk hacked by cyber extortion group FulcrumSec.* The group claims **over two months** of infiltration, targeting sensitive data. No immediate financial impact reported; operations appear stable. Incident highlights rising cyber risks for global pharma firms. 📊 *STOCKS:* | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CyberSecurity